On August 29, CJSC CV Protek (a subsidiary of OAO Protek) acquired 0.1992% of the shares in OAO Protek, the latter company informed.
As a result, the share of CV Protek in OAO Protek has increased to 2.3731% from 2.1738%.
Protek Group (tax number: 7715354473) is a Russian pharmaceuticals distributor. The group's key companies in various segments are: national distributor of pharmaceuticals and healthcare & beauty products CJSC CV Protek, network of pharmacies Rigla and pharmaceutical manufacturer FarmFirma Sotex.
In H1 2014, Protek Group increased its revenue under IFRS by 7.1% to RUB 71.275 billion from RUB 66.58 billion the year before. GP was RUB 8.797 billion against RUB 8.646 billion (+1.7%). Gross margin decreased to 12.3% from 13%. EBITDA grew by 1.59% to RUB 1.856 billion from RUB 1.827 billion. EBITDA margin was 2.6% against 2.7% the year before.
According to the DataCapital information retrieval system, RAS net profit of OAO Protek for H1 2014 decreased 2.5 times to RUB 1.04 billion from RUB 2.6 billion the year before. Revenue increased by 9% to RUB 71.709 million from RUB 65.81 million, GP by 21% to RUB 7.988 million from RUB 6.593 million. Pre-tax profit decreased by 60% year-on-year to RUB 1.051 million from RUB 2.617 billion.